Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Voting Common Shares, no par value
-
Shares outstanding
-
51,654,406
-
Total 13F shares
-
5,062,392
-
Share change
-
+462,603
-
Total reported value
-
$14,934,296
-
Put/Call ratio
-
77%
-
Price per share
-
$2.95
-
Number of holders
-
32
-
Value change
-
+$1,369,211
-
Number of buys
-
10
-
Number of sells
-
13
Institutional Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q2 2024
As of 30 Jun 2024,
DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,062,392 shares.
The largest 10 holders included
COOPERMAN LEON G, VANGUARD GROUP INC, FIRST MANHATTAN CO. LLC., PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE, Bleichroeder LP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, Aristides Capital LLC, BlackRock Inc., and MORGAN STANLEY.
This page lists
32
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.